Among the molecular pathways altered in CRC, aberrant hyperactivation of Nuclear factor erythroid 2 (NF-E2) p45-related factor 2 (NRF2) can occur and correlates with poor patients’ prognosis [3,4]. This evidence concerns the gene NFE2L2 and colorectal carcinoma.